These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 2415994

  • 1. Lung hypersensitivity responses: dissociation of human lung mast cell leukotriene C4 (LTC4) from histamine release.
    Schulman ES, Anderson CL.
    Prog Clin Biol Res; 1985; 199():209-20. PubMed ID: 2415994
    [No Abstract] [Full Text] [Related]

  • 2. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.
    Levi-Schaffer F, Austen KF, Caulfield JP, Hein A, Gravallese PM, Stevens RL.
    J Immunol; 1987 Jul 15; 139(2):494-500. PubMed ID: 2439587
    [Abstract] [Full Text] [Related]

  • 3. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ, Peachell PT, Lichtenstein LM.
    J Pharmacol Exp Ther; 1988 Oct 15; 247(1):209-17. PubMed ID: 2459368
    [Abstract] [Full Text] [Related]

  • 4. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
    Levi-Schaffer F, Dayton ET, Austen KF, Hein A, Caulfield JP, Gravallese PM, Liu FT, Stevens RL.
    J Immunol; 1987 Nov 15; 139(10):3431-41. PubMed ID: 2445814
    [Abstract] [Full Text] [Related]

  • 5. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.
    Wells E, Harper ST, Jackson CG, Mann J, Eady RP.
    J Immunol; 1986 Dec 15; 137(12):3933-40. PubMed ID: 2431048
    [Abstract] [Full Text] [Related]

  • 6. Interrelationships of SRS-A production and arachidonic acid metabolism in human lung tissue.
    Walker JL.
    Adv Prostaglandin Thromboxane Res; 1980 Dec 15; 6():115-9. PubMed ID: 6155760
    [No Abstract] [Full Text] [Related]

  • 7. The role of mast cells in the pathogenesis of asthma.
    Holgate ST.
    Bull Eur Physiopathol Respir; 1985 Dec 15; 21(5):449-62. PubMed ID: 2415192
    [No Abstract] [Full Text] [Related]

  • 8. Isolation and characterization of human intestinal mucosal mast cells.
    Fox CC, Dvorak AM, Peters SP, Kagey-Sobotka A, Lichtenstein LM.
    J Immunol; 1985 Jul 15; 135(1):483-91. PubMed ID: 2582045
    [Abstract] [Full Text] [Related]

  • 9. Mast cell-dependent immediate hypersensitivity responses.
    Lewis RA.
    Prog Clin Biol Res; 1986 Jul 15; 213():457-70. PubMed ID: 3086897
    [No Abstract] [Full Text] [Related]

  • 10. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
    Holgate ST, Burns GB, Robinson C, Church MK.
    J Immunol; 1984 Oct 15; 133(4):2138-44. PubMed ID: 6206153
    [Abstract] [Full Text] [Related]

  • 11. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V, Meliota S, Marino O, Patella V, de Paulis A, Guidi G, Marone G.
    J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1375-85. PubMed ID: 7505332
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.
    Schulman ES, Post TJ, Henson PM, Giclas PC.
    J Clin Invest; 1988 Mar 15; 81(3):918-23. PubMed ID: 2449462
    [Abstract] [Full Text] [Related]

  • 13. Formation of PGD2 after allergen inhalation in atopic asthmatics.
    Sladek K, Sheller JR, FitzGerald GA, Morrow JD, Roberts LJ.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Mar 15; 21A():433-6. PubMed ID: 1847781
    [No Abstract] [Full Text] [Related]

  • 14. The pharmacologic control of mediator release from human basophils and mast cells.
    Peters SP, Naclerio RM, Schleimer RP, MacGlashan DW, Pipkorn U, Lichtenstein LM.
    Respiration; 1986 Mar 15; 50 Suppl 2():116-22. PubMed ID: 3494282
    [Abstract] [Full Text] [Related]

  • 15. Increased adventitial mast cells in a patient with coronary spasm.
    Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R.
    N Engl J Med; 1985 Oct 31; 313(18):1138-41. PubMed ID: 2413358
    [No Abstract] [Full Text] [Related]

  • 16. Adenosine and eicosanoid release from immunologically challenged human lung fragments.
    Viganò T, Toia A, Galli G, Berti F, Crivellari MT, Mezzetti M, Folco GC.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Oct 31; 17B():992-6. PubMed ID: 2823581
    [No Abstract] [Full Text] [Related]

  • 17. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity.
    Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM.
    J Immunol; 1987 Nov 01; 139(9):3062-9. PubMed ID: 2444649
    [Abstract] [Full Text] [Related]

  • 18. General anaesthetics induce only histamine release selectively from human mast cells.
    Stellato C, Casolaro V, Ciccarelli A, Mastronardi P, Mazzarella B, Marone G.
    Br J Anaesth; 1991 Dec 01; 67(6):751-8. PubMed ID: 1722691
    [Abstract] [Full Text] [Related]

  • 19. Mediator release from human basophils and mast cells from lung and intestinal mucosa.
    Fox CC, Kagey-Sobotka A, Schleimer RP, Peters SP, MacGlashan DW, Lichtenstein LM.
    Int Arch Allergy Appl Immunol; 1985 Dec 01; 77(1-2):130-6. PubMed ID: 2409011
    [No Abstract] [Full Text] [Related]

  • 20. The release and role of inflammatory mediators in asthma.
    Holgate ST, Robinson C, Church MK, Howarth PH.
    Clin Immunol Rev; 1985 Dec 01; 4(2):241-88. PubMed ID: 2417772
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.